Ratings Aegon Ltd. Nyse

Equities

AEG

US0076CA1045

Market Closed - Nyse Other stock markets 16:00:02 2024-05-15 EDT			5-day change	1st Jan Change
6.76 ^USD	+0.75%		+4.64%	+17.36%

05-14	Anglo shareholder welcomes proposed strategic revamp	RE
05-14	AEGON A.M. SAYS REVAMP APPEARS TO GIVE INVESTORS "A MARKED SIMPL…	RE

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

Its low valuation, with P/E ratio at 8.49 and 7.34 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
AEGON LTD.	+17.36%	11.7B	-
AXA	+13.16%	79.54B	B-
METLIFE, INC.	+10.59%	52.13B	B+
AFLAC INCORPORATED	+6.04%	49.04B	B
MANULIFE FINANCIAL CORPORATION	+21.41%	46.7B	B+
PRUDENTIAL FINANCIAL, INC.	+15.32%	42.69B	B+
GENERALI	+28.76%	41.44B	B
SUN LIFE FINANCIAL INC.	+0.65%	29.51B	B
GREAT-WEST LIFECO INC.	-3.35%	29.11B	B-
PRUDENTIAL PLC	-9.40%	27.32B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes